Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery.

MLA

Ma, Jennifer, et al. “Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery.” European Urology Oncology, Aug. 2024. EBSCOhost, https://doi.org/10.1016/j.euo.2024.07.005.

APA

Ma, J., Del Balzo, L., Walch, H., Khaleel, S., Knezevic, A., Flynn, J., Zhang, Z., Eichholz, J., Doshi, S. D., Voss, M. H., Freeman, B., Ari Hakimi, A., Lee, C.-H., Bale, T. A., Kelly, D., Mueller, B. A., Mann, J., Yu, Y., Zinovoy, M., … Pike, L. R. G. (2024). Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery. European Urology Oncology. https://doi.org/10.1016/j.euo.2024.07.005

Chicago

Ma, Jennifer, Luke Del Balzo, Henry Walch, Sari Khaleel, Andrea Knezevic, Jessica Flynn, Zhigang Zhang, et al. 2024. “Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery.” European Urology Oncology, August. doi:10.1016/j.euo.2024.07.005.